Your browser is no longer supported. Please, upgrade your browser.
Settings
LIVN LivaNova PLC daily Stock Chart
LIVN [NASD]
LivaNova PLC
Index- P/E187.32 EPS (ttm)0.53 Insider Own0.40% Shs Outstand48.64M Perf Week6.18%
Market Cap4.86B Forward P/E26.22 EPS next Y3.81 Insider Trans- Shs Float48.47M Perf Month8.15%
Income26.40M PEG17.51 EPS next Q1.10 Inst Own95.20% Short Float2.35% Perf Quarter-18.77%
Sales906.10M P/S5.36 EPS this Y0.30% Inst Trans-0.68% Short Ratio2.12 Perf Half Y-19.12%
Book/sh36.70 P/B2.72 EPS next Y7.30% ROA-3.50% Target Price128.00 Perf Year16.30%
Cash/sh1.64 P/C60.77 EPS next 5Y10.70% ROE-5.00% 52W Range79.96 - 131.54 Perf YTD9.15%
Dividend- P/FCF59.15 EPS past 5Y0.60% ROI5.30% 52W High-24.10% Beta0.73
Dividend %- Quick Ratio1.20 Sales past 5Y31.80% Gross Margin64.80% 52W Low24.86% ATR3.10
Employees4500 Current Ratio1.70 Sales Q/Q8.30% Oper. Margin5.00% RSI (14)68.91 Volatility4.39% 3.20%
OptionableYes Debt/Eq0.09 EPS Q/Q-123.20% Profit Margin-10.00% Rel Volume0.66 Prev Close99.10
ShortableYes LT Debt/Eq0.06 EarningsFeb 27 BMO Payout- Avg Volume537.74K Price99.84
Recom2.10 SMA208.71% SMA509.01% SMA200-4.99% Volume378,639 Change0.75%
Nov-28-18Initiated UBS Neutral $105
Aug-02-18Reiterated Needham Buy $128 → $135
Jun-08-18Initiated Stifel Buy $115
May-31-18Reiterated Needham Buy $102 → $106
Feb-28-18Reiterated Needham Buy $97 → $104
Feb-20-19 10:31AM  LivaNova (LIVN) Earnings Expected to Grow: Should You Buy? Zacks
Feb-15-19 11:21AM  LivaNova Recognizes Final Decision from the U.S. Centers for Medicare & Medicaid Services Regarding National Coverage Determination for VNS Therapy for Treatment-Resistant Depression Business Wire +6.42%
Jan-28-19 09:00AM  LivaNova to Host Conference Call for Fourth Quarter and Full-Year 2018 Results Business Wire
Jan-17-19 09:00AM  New Studies in the U.S. and Europe Demonstrate LivaNova Perceval Valves Strong Performance and Economic Advantage in Aortic Disease Treatment Business Wire
Jan-03-19 07:25AM  Consolidated Research: 2019 Summary Expectations for Tahoe Resources, LivaNova, World Acceptance, Community Healthcare Trust, MarketAxess, and Bonanza Creek Energy Fundamental Analysis, Key Performance Indications GlobeNewswire -5.36%
Dec-10-18 12:28PM  LivaNova PLC (LIVN)Hedge Funds Are Snapping Up Insider Monkey
Nov-29-18 07:50AM  Report: Exploring Fundamental Drivers Behind Resonant, Constellation Brands, Masimo, Tetraphase Pharmaceuticals, LivaNova, and Penumbra New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-26-18 09:00AM  LivaNova Partners with Greg Grunberg to Raise Epilepsy Awareness Business Wire
Nov-20-18 04:49PM  Why L Brands, Devon Energy, and LivaNova Slumped Today Motley Fool -18.41%
01:10PM  Here's Why LivaNova Dropped Today Motley Fool
07:36AM  LivaNova Comments on Proposed Decision Memo from the U.S. Centers for Medicare & Medicaid Services Regarding National Coverage Determination for VNS Therapy for Treatment-Resistant Depression Business Wire
Nov-19-18 09:00AM  LivaNova to Present at the Piper Jaffray and Berenberg Conferences Business Wire
Oct-31-18 12:39PM  LivaNova PLC (LIVN) Q3 2018 Earnings Conference Call Transcript Motley Fool
07:35AM  LivaNova (LIVN) Misses Q3 Earnings and Revenue Estimates Zacks
06:00AM  LivaNova Reports Third Quarter 2018 Results Business Wire
Oct-30-18 09:40AM  Medical Product Stock Q3 Earnings on Oct 31: BAX, MASI & More Zacks
Oct-24-18 09:00AM  LivaNova to Present at the Stifel 2018 Healthcare Conference Business Wire
Oct-22-18 07:55AM  Recent Analysis Shows Crestwood Equity Partners LP, The Goldman Sachs Group, Lam Research, RYB Education, Inc. Sponsored ADR, Ecolab, and LivaNova Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Sep-26-18 09:00AM  LivaNova to Host Conference Call for Third Quarter 2018 Results Business Wire
Sep-18-18 09:00AM  LivaNova Launches International Pivotal Study Evaluating Use of Autonomic Regulation Therapy for Heart Failure Business Wire
Sep-10-18 09:00AM  LivaNova Welcomes NICE Interventional Procedures Guidance on Sutureless Aortic Valve Replacement Business Wire
Sep-04-18 09:00AM  LivaNova VNS Therapy System for Drug-Resistant Epilepsy Could Save $77,000 Per Patient Over Five Years Business Wire
Aug-23-18 09:28AM  LivaNova Launches Global Clinical Registry to Assess VNS Therapy Treatment for Drug-Resistant Epilepsy Patients Business Wire
Aug-22-18 09:00AM  LivaNova to Present at Morgan Stanley Global Healthcare Conference Business Wire
Aug-06-18 09:00AM  LivaNova Concludes PRELUDE Study for Transcatheter Mitral Valve Replacement System Business Wire
Aug-02-18 04:43PM  Healthcare Bulls Get a Second Dose of Earnings-Driven Profits TheStreet.com
08:48AM  LivaNova (LIVN) Soars: Stock Adds 10.4% in Session Zacks
Aug-01-18 08:19AM  LivaNova (LIVN) Tops Q2 Earnings and Revenue Estimates Zacks +10.41%
06:00AM  LivaNova Reports Second Quarter 2018 Results Business Wire
06:00AM  Livanova PLC to Host Earnings Call ACCESSWIRE
Jul-10-18 07:30AM  Free Technical Reports on InspireMD and Three Additional Medical Equipment Equities ACCESSWIRE
Jul-03-18 09:00AM  LivaNova to Host Conference Call for Second Quarter 2018 Results Business Wire
Jun-15-18 07:50AM  Analysis: Positioning to Benefit within Vector Group, The Goldman Sachs Group, LivaNova, IRSA Inversiones Y Representaciones S.A, T. Rowe Price Group, and First Solar Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jun-14-18 09:00AM  LivaNova Receives FDA Clearance and Completes First Implant for its MEMO 4D Semi-rigid Mitral Annuloplasty Ring Business Wire
Jun-13-18 09:00AM  LivaNova Welcomes William Kozy to Board of Directors Business Wire
Jun-11-18 09:00AM  LivaNovas Perceval Sutureless Aortic Heart Valve Approved in Japan Business Wire
Jun-08-18 10:41AM  LivaNova Valuation Multiples Likely to Increase Amid Steady Progress, Stifel Says In Bullish Initiation Benzinga
Jun-04-18 07:30AM  Free Daily Technical Summary Reports on LivaNova and Three Other Medical Equipment Stocks ACCESSWIRE
May-31-18 03:32PM  Here's Why LivaNova Rose as Much as 13% Today Motley Fool +13.33%
09:30AM  LivaNova to Present at the Jefferies and Goldman Sachs Conferences Business Wire
May-30-18 05:43PM  LivaNova Comments on the U.S. Centers for Medicare & Medicaid Services Reconsideration of its National Coverage Determination for VNS Therapy for Treatment-Resistant Depression Business Wire
May-02-18 09:01AM  LivaNova: 1Q Earnings Snapshot Associated Press -6.95%
07:00AM  LivaNova Reports First Quarter 2018 Results Business Wire
Apr-30-18 07:17AM  LivaNova Completes Sale of Cardiac Rhythm Management Business to MicroPort Scientific Corporation Business Wire
Apr-26-18 09:00AM  LivaNova Announces One-Millionth Inspire Adult Oxygenator Patient Business Wire
Apr-18-18 07:55AM  New Research: Key Drivers of Growth for Bonanza Creek Energy, MarketAxess, LivaNova, Cintas, Bio-Techne, and Provident Financial Services Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Apr-17-18 08:14AM  LivaNova Receives CE Mark for VNS Therapy SenTiva Generator and Next-Generation Programming System for Treatment of Epilepsy Business Wire
Apr-05-18 09:00AM  LivaNova to Host Conference Call for First Quarter 2018 Results Business Wire
Apr-04-18 04:30PM  LivaNova Completes Acquisition of TandemLife Business Wire
Mar-29-18 09:00AM  LivaNova Bicarbon Aortic Valves Receive CE Mark for Expanded Use Labeling with Lower-Dose Blood Thinners in Low-Risk Patients Business Wire
Mar-28-18 09:02AM  LivaNova Commences Clinical Study to Evaluate Treatment Outcomes for Novel Microburst VNS Therapy System Business Wire
Mar-22-18 09:51AM  LivaNova Announces Enrollment for PERFECT Perceval Valve Clinical Trial in China Business Wire
Mar-20-18 10:22AM  LivaNova to Present at the Needham & Company Healthcare Conference Business Wire
Mar-14-18 07:50AM  Report: Developing Opportunities within AveXis, LivaNova, FRP, Ross Stores, R1 RCM, and Criteo S.A Future Expectations, Projections Moving into 2018 GlobeNewswire
Mar-08-18 04:22AM  BRIEF-Microport Scientific Updates On Acquisition Of Business From Livanova PLC Reuters
03:30AM  LivaNova Enters into Definitive Agreement to Divest Its Cardiac Rhythm Management Business Franchise to MicroPort Scientific Corporation Business Wire
Feb-28-18 08:11AM  LivaNova reports 4Q loss Associated Press
07:00AM  LivaNova Reports Fourth Quarter and Full-Year 2017 Results Business Wire
06:50AM  Livanova PLC to Host Earnings Call ACCESSWIRE
Feb-15-18 09:00AM  LivaNova to Present at the Barclays and Cowen Conferences Business Wire
Feb-14-18 04:05PM  LivaNova to Acquire TandemLife Business Wire
Feb-01-18 09:46AM  LivaNova Announces CE Mark for PureFlex Arterial Cannulae Line for Conventional Cardiac Surgery Business Wire
Jan-24-18 09:00AM  LivaNova to Host Conference Call for Fourth Quarter and Full-Year 2017 Results Business Wire
Jan-11-18 09:00AM  LivaNova Initiates BELIEVE Aortic Heart Valve Study in the U.S. and Canada Business Wire
Jan-08-18 09:00AM  LivaNova Announces Matthew J. Dodds as Senior Vice President, Corporate Development Business Wire
Jan-04-18 12:49PM  LivaNova Commences Global RESTORE-LIFE Study for Treatment-Resistant Depression Business Wire
Dec-21-17 07:26AM  LivaNova Plc breached its 50 day moving average in a Bearish Manner : LIVN-US : December 21, 2017 Capital Cube
Dec-14-17 03:05PM  4 Growth Stocks to Pick From a Choppy MedTech Market InvestorPlace
10:24AM  4 Growth Stocks to Pick From a Choppy MedTech Market Zacks
Dec-05-17 03:01AM  LivaNova to Acquire ImThera Medical, Inc. Business Wire
Nov-20-17 06:40AM  BRIEF-LivaNova says breaching co to pay $6 mln if deal with Microport collapses Reuters
05:07AM  BRIEF-Microport Scientific's unit buys CRM business from Livanova Reuters
03:43AM  LivaNova Enters into Binding Letter of Intent to Sell its Cardiac Rhythm Management Business Franchise to MicroPort Scientific Corporation for $190 Million Business Wire
Nov-14-17 10:14AM  4 Top Growth Picks to Avoid Tax Tangle in MedTech Zacks
Nov-07-17 09:00AM  LivaNova to Present at the Piper Jaffray and Berenberg Conferences Business Wire
Nov-02-17 08:25AM  LivaNova posts 3Q profit Associated Press +6.70%
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates in two segments, Cardiac Surgery and Neuromodulation. The Cardiac Surgery segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, perfusion tubing systems, cannulae and accessories for extracorporeal circulation, and systems for autotransfusion and autologous blood washing, as well as surgical tissue and mechanical heart valve replacements, and repair products for damaged or diseased heart valves. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy and treatment-resistant depression. The company's product portfolio also includes various strategic portfolio initiatives, such as transcatheter mitral valve replacement, an implant device for the treatment of mitral regurgitation through the replacement of native mitral valve; VITARIA to treat heart failure through VNS; and ANTHEM-HFpEF to study autonomic regulation therapy in patients experiencing symptomatic heart failure with preserved ejection fraction, as well as treatment resistant depression. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.